HHealthcare Read More Eli Lilly will file for approval of retatrutide obesity drug in 2027July 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
MMedication Read More Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat petJuly 18, 2026 A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
HHealthcare Read More GLP-1 implant from Vivani Medical aims to help patients stay on treatmentJuly 11, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
HHealthcare Read More Employers aren’t expanding coverage of GLP-1 obesity drugs: surveyJuly 8, 2026 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
HHealthcare Read More Medicare obesity drug GLP-1 coverage starting July 1July 1, 2026 Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
HHealthcare Read More Medicare will soon cover obesity drugs, but many seniors may not knowJune 28, 2026 Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news…
MMedication Read More GLP-1 weight loss pills may be bad thing for job insurance coverageJune 26, 2026 The new GLP-1 pills are likely to boost consumer demand for these popular weight-loss drugs. But it could…
HHealthcare Read More UPS to invest $48 million in cold facilities amid GLP-1 boomJune 22, 2026 United Parcel Service (UPS) trucks are parked at a UPS drop yard on Oct. 28, 2025 in Vernon,…
HHealthcare Read More Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverageJune 8, 2026 Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
BBusiness Read More Weight loss drug maker stock sinks 25% as safety data spooks investorsJune 8, 2026 Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
HHealthcare Read More CVS restores Zepbound coverage, adds Eli Lilly’s obesity pill FoundayoMay 28, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on…
AArtificial intelligence Read More Global market reordering is accelerating as the AI rally gains paceMay 20, 2026 The Wall Street bull stands in the financial district near the New York Stock Exchange on Nov. 18,…